Laminin overlay assay
WebMay 25, 2024 · ( B) Western blot of core α-DG and β-DG (AF6868), matriglycan-positive α-DG (IIH6), or laminin (Laminin OL) in (A). ( C) Solid-phase binding assay. ( D) Representative cryosections stained with hematoxylin and eosin (H&E) or Sirius red and Fast Green, or used for immunofluorescence: β-DG (AP83); matriglycan-positive α-DG … WebApr 20, 2011 · Overexpression of LARGE was studied in DG-deficient neural stem cells using immunobloting with IIH6C4 and VIA4-1 antibodies in conjunction with a laminin …
Laminin overlay assay
Did you know?
WebAug 4, 2009 · In this assay, muscle fibers are irradiated with a mode-locked Ti-Sapphire infrared (IR) laser at 880 nm wavelength to induce the loss of membrane integrity at a … WebA laminin-binding assay confirmed that the T192→M mutation considerably reduces the effectiveness of dystroglycan as a laminin receptor ( Figure 1D, and Figure 1B and 1C in …
WebJan 1, 2010 · The products were subjected to either immunoblotting with CORE antibody or laminin overlay assay. To verify that α-DG is phosphorylated, we labeled human … WebMar 20, 2012 · Brain slice overlay assay. Brain slice overlay assay was performed by following the methods described previously 72, 73. Briefly, coronal sections (300 μm) of neonatal rat cerebral cortex were ...
WebBiotin-labeled laminin-1 overlay assay of dissociated BAE membrane proteins indicated the interaction of laminin-1 with αDG. The laminin α5 globular domain fragment expressed in bacteria and labeled with biotin could also bind αDG on the membrane blot, and the unlabeled fragment disrupted the binding of biotin-laminin-1 to αDG. WebApr 29, 2016 · WGA-enriched cell lysates from control and TMEM5 P1 fibroblasts were subjected to biochemical analysis. α-DG glycosylation status as assessed by western blotting using antibodies against the glycosylated form of α-DG (IIH6), core α-DG (G6317), and by laminin overlay assay (N = 3). An antibody against β-DG (AP83) was used to …
WebSep 11, 2013 · Human Laminin in vitro ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the accurate quantitative measurement of Human Laminin in cell culture …
WebOct 14, 2024 · Western blot demonstrates reduced alpha-dystroglycan glycosylation and laminin binding in muscle. Representative image for Western blot (A) and laminin overlay assay (B) (Individual 1). A reduction in the glycosylated smear of the individual, both in intensity and in molecular weight, was observed compared to the control with antibody IIH6. c terminal vs n terminalWebThese comprehensive analyses of the interactions between laminin-binding integrins and a panel of laminins clearly demonstrate that the isoforms of both integrins and laminins differ in their binding specificities and affinities, and provide a molecular basis for better understanding of the adhesive interactions of cells with basement membranes … marco rendeliWebDec 1, 2008 · More sensitive methods detected minor levels of intact α-dystroglycan, and solid-phase assays determined laminin binding levels to be ∼50% of normal. In … marco-remontit oyWebRepresentative image for western blot (a) and laminin overlay assay (b) (individual 1). A reduction in the glycosylated smear of the individual, both in intensity and in molecular weight, was ... marco rene gabelmannWebApr 23, 1999 · Biotin-labeled laminin-1 overlay assay of dissociated BAE membrane proteins indicated the interaction of laminin-1 with alphaDG. The laminin alpha5 … marco rene criollo garciaWebMar 8, 2016 · (B) Western blot analysis and laminin overlay assay of the DGFc proteins. DGFc (full-length), DGFc WT, DGFc T190M, and DGFc T320K were subjected to western blotting with a biotinylated anti-Fc antibody, IIH6 antibody, and to the laminin overlay assay. (C–E) MALDI mass spectra of DGFc-derived glycopeptides. (C) DG WT-GP (0.5 … c terminal tagWebFeb 1, 2024 · This smaller form of α-DG binds laminin and maintains specific force but does not prevent muscle pathophysiology, including reduced force production after eccentric contractions (ECs) or abnormalities in the neuromuscular junctions. marco-remontit